A Comparative Dissolution Kinetics Test for Omeprazole-Containing Medicines, Reproducing Secretory and Motor-Evacuatory Impairments the Stomach of Patients with Acid-Dependent Diseases


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A comparative dissolution kinetics test was used to study the release (dissolution kinetics) of an original and 10 generic formulations of omeprazole from different manufacturers in a medium simulating the moderately acidic conditions in the stomach typical of the state of medication-induced suppression of acidity; tests were also performed in a model of pathological duodenogastric reflux. HPLC was used to measure omeprazole concentrations in aliquots collected at 4, 10, 15, 20, 30, 45, and 60 min in solution with pH 7.0 ± 0.05 after 2 h of exposure at pH 1.2 ± 0.05 or 4.0 ± 0.05. The duration of action of pathological duodenogastric reflux on the therapeutic formulations of omeprazole was 4 min. Not all the study formulations could be completely recognized as equivalents to the original formulation in the in vitro test conditions.

作者简介

G. Vasilenko

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

L. Krasnykh

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

S. Serebrova

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

A. Prokof’ev

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

G. Ramenskaya

Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
俄罗斯联邦, Building 2, 8 Petrovskii Boulevard, Moscow, 127051; Building 2, Moscow

E. Smolyarchuk

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
俄罗斯联邦, Building 2, Moscow

D. Kurguzova

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
俄罗斯联邦, Building 2, Moscow

A. Barkov

I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)

Email: chem@folium.ru
俄罗斯联邦, Building 2, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2017
##common.cookie##